FGFR2 INHIBITORS FOR THE TREATMENT OF CHOLANGIOCARCINOMA

• 收藏
• 分享

专利权人:

Janssen Pharmaceutica NV

发明人:

Jacqueline Cirillo BUSSOLARI

申请号：

US16616067

公开号：

US20200138809A1

申请日:

2018.06.01

申请国别(地区):

US

年份:

2020

代理人:

摘要：

Disclosed herein are methods of treating cholangiocarcinoma in a patient comprising: evaluating a biological sample from the patient for the presence of one or more FGFR mutants including at least the FGFR2 SNP C383R； and treating the patient with an FGFR inhibitor if one or more FGFR mutants including at least the FGFR2 SNP C383R are present in the sample.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/